Joanna Jen is a Neurology physician. OpenAlex indexes 157 publications with 9,393 citations (h-index 50); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Medical Plaza
#b200
Los Angeles, CA 90095
Telephone
310-794-1195Registry record last updated 21 Oct 2010.
Clinical trials
- 4-Aminopyridine in Episodic Ataxia Type 2
Sponsor: University of California, Los Angeles
- Characteristics of Episodic Ataxia Syndrome
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- UCB, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
8 NIH research awards on record, funded 1998–2011 per NIH RePORTER. The latest:
- Phase 2 Study of 4-Aminopyridine for the Treatment of Episodic Ataxia Type 2
University of California Los Angeles
FY2011$199,935R01FD003923 - Pathobiology of Retinal Vasculopathy with Cerebal Leukodystrophy (RVCL)
University of California Los Angeles
FY2010$552,119R01NS062069
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bilateral vestibulopathy: Diagnostic criteria Consensus document of the Classification Committee of the Bárány Society1
Journal of Vestibular Research
2017 - Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria
Molecular Biology of the Cell
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”